Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06365619
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-04-09
Brief Title:
Neoadjuvant IpilimumabNivolumab for Patients With Recurrent High Risk Resectable Melanoma
Sponsor:
Organization:
University of Utah